title: [Renal cell carcinoma].
abstract: Approximately 85% of all malignant tumors of the kidney are renal cell carcinomas (RCC). Sonography is the leading examination for early detection of kidney tumors. The treatment of RCC has been enriched in recent years by new therapeutic options for localized and metastatic cancer. The classification of RCC is based on TNM and UICC criteria. The so-called Motzer criteria are being increasingly employed to assess prognosis and monitor therapy and as the basis for reaching decisions on choosing the type of systemic treatment.
authors.affiliation: Universitätsklinik und Poliklinik für Urologie und Nierentransplantation, Martin-Luther-Universität Halle-Wittenberg, Ernst Grube-Strasse 40, Halle, Germany. direktor.urologie@medizin.uni-halle.de
authors.forename: P
authors.initials: P
authors.lastname: Fornara
authors.forename: M R
authors.initials: MR
authors.lastname: Hoda
mesh_terms: D000465:Algorithms; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D016503:Drug Delivery Systems; D042241:Early Diagnosis; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D010535:Laparoscopy / Q000379:methods; D008207:Lymphatic Metastasis / Q000473:pathology; D009367:Neoplasm Staging; D009392:Nephrectomy / Q000379:methods; D059351:Organ Sparing Treatments / Q000379:methods; D011379:Prognosis; D014463:Ultrasonography
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor